Plain-English translation of NCT07008742 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a study about collecting blood and tumor tissue samples from people with non-small cell lung cancer. Researchers want to understand how well they can gather these samples from patients at different stages of treatment — some starting new targeted drugs for advanced cancer, and others receiving immunotherapy before surgery for early-stage cancer. The samples will help doctors learn more about how tumors respond to treatment.
Doctors now have new ways to treat lung cancer based on the specific genetic changes in each person's tumor. To make these personalized treatments work better, researchers need to collect high-quality tumor tissue and blood samples to study how cancers respond and change over time. This study is checking whether it's practical to collect these samples in real-world patient care.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood samples drawn and tumor tissue samples collected (either before starting treatment, when your cancer progresses, or during surgery, depending on which group you are in). These samples will be analyzed to study your tumor's genetic features and how it responds to treatment. Your participation will involve regular visits aligned with your standard cancer care appointments.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United Kingdom